Skip to main content

Need urgent help? Start triage first, then route to emergency care.

Meds A-Z

Cephapirin Sodium

Detailed information about Cephapirin Sodium

Official label facts Owner quick guide first Marketing clearly labeled
Showing simplified owner view. Switch to Vet View for full technical detail.

Pet Owner Quick Guide

Start here: what this medicine is for, what it does, and when it's usually needed.

Usually used for:

ToDAY (cephapirin sodium intramammary infusion) should be used should be used at the first signs of inflammation or at the first indication of any alteration in the milk. Treatment is indicated immediately upon determini...

What it does:

ToDAY (cephapirin sodium intramammary infusion) should be used should be used at the first signs of inflammation or at the first indication of any alteration in the milk. Treatment is indicated immediately upon determini...

When it's needed:

ToDAY (cephapirin sodium intramammary infusion) should be used should be used at the first signs of inflammation or at the first indication of any alteration in the milk. Treatment is indicated immediately upon determini...

Commonly reported reactions:

  • (1 reports)
  • (1 reports)

What to ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Talk to a Vet / Find a Vet Near You
Image coming soon
Cephapirin Sodium

Cephapirin Sodium

Drug type: Generic ingredient • Branded profile FDA branded products available

Species: Both

Manufacturer: Boehringer lngelheim Animal Health USA, Inc.

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Boehringer lngelheim Animal Health USA, Inc.
Form: Suspension
Identifiers:
NADA: 97222 NDC Package: 0010-4754-01 NDC Package: 0010-4754-02 NDC Product: 0010
Source metadata:

Warnings / Contraindications

No contraindication summary is linked yet.

No owner-focused warning rows are linked yet.

Source metadata: No source yet.

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
4
Reported cases
2
Serious reports
2
Species represented
1
Most Reported Reactions
Reaction Cases Species Serious cases
1 Dog 1
1 Dog 1
0 Dog 0
0 Dog 0

Species coverage: Dog (4)

View detailed reaction table
Reaction Species Seriousness Frequency Reports
Dog Serious - 1
Dog Serious - 1
Dog Unknown - -
Dog Unknown - -
Source metadata:

Storage & Handling

No storage/handling guidance is linked yet.

Source metadata: No source yet.

Documents

Official label facts are separated from secondary summaries.

Official documents: 1 • Secondary summaries: 0

Official label facts
Secondary summaries

No source yet.

Promotional Materials (Marketing)

This content is marketing material and not clinical guidance.

No marketing assets are linked yet.

No source yet.

Source metadata: No source yet.
Talk to a Vet / Find a Vet Near You
Technical appendix (vet reference)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Feb 16, 2026, 11:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Feb 16, 2026, 11:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Feb 9, 2026, 3:15 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: ToDAY®
Case-reported brands (openFDA): MSK
Catalog species: Both FDA-labeled species: Lactating cows
Rx/OTC: RX
Form/route: Suspension Intramammary
Applications: NADA 97222
Documents: • SPL: 1 Label highlights Official documents
Safety (openFDA)
Top reactions: Dog 2 Cat 0 View
Case summaries: 1 (showing 1) View
openFDA reports are unverified and do not prove causation.

Explore
Related conditions: Mastitis
Linked using: Fda_Label (0.95)

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Top reaction signals
Deafness (1) Skin lump (1) Deafness (reports: 1, since 2016-02-12) (0) Skin lump (reports: 1, since 2016-02-12) (0)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NADA: 97222 NDC Package: 0010-4754-01 NDC Package: 0010-4754-02 NDC Product: 0010
Package NDC Product NDC Form / Route Status
0010-4754-01 0010 -
0010-4754-02 0010 -

Data Sources & Revision History

Every non-trivial field is expected to include provenance and update timestamps.

Official 2 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • side_effects: Top reported reactions (openFDA): Deafness, Skin lump. (Official, 2026-02-12)
  • usage: ToDAY (cephapirin sodium intramammary infusion) should be used should be used at the first signs of inflammation or at the first indication of any alteration i… (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
ToDAY®
RX
Cephapirin Sodium
Suspension Intramammary
Boehringer lngelheim Animal Health USA, Inc. NADA 97222 Approved Jul 31, 2025

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Lactating cows
Composition / specifications
Each 10 mL syringe contains 200 mg of cephapirin activity
Lactating cows
Indication

ToDAY (cephapirin sodium intramammary infusion) should be used should be used at the first signs of inflammation or at the first indication of any alteration in the milk. Treatment is indicated immediately upon determining, by C.M.T. or other tests, that the leukocyte count is elevated, or that a susceptible pathogen has been cultured from the milk. ToDAY has been shown to be efficacious in the treatment of mastitis in lactating cows caused by susceptible strains of Streptococcus agalactiae and Staphylococcus aureus including strains resistant to penicillin.

Dosage

Infuse the entire contents of one syringe (10 mL) into each infected quarter immediately after the quarter has been completely milked out. Repeat once only in 12 hours. If definite improvement is not noted within 48 hours after treatment, the causal organism should be further investigated. Consult your veterinarian. Do not milk out for 12 hours.

Limitations

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Usage

ToDAY (cephapirin sodium intramammary infusion) should be used should be used at the first signs of inflammation or at the first indication of any alteration in the milk. Treatment is indicated immediately upon determining, by C.M.T. or other tests, that the leukocyte count is elevated, or that a susceptible pathogen has been cultured from the milk. ToDAY has been shown to be efficacious in the treatment of mastitis in lactating cows caused by susceptible strains of Streptococcus agalactiae and Staphylococcus aureus including strains resistant to penicillin.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

No approved contraindication text is linked yet. Review FDA label highlights and openFDA safety reports before making treatment decisions.

Side Effects

No approved side-effect narrative is linked yet.

openFDA reaction signals are available for Dog 2 and Cat 0 (view top reported reactions).

Top Reported Reactions (openFDA)

Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).

Dog
Other
Deafness (1) Skin lump (1)

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Pug, Male, 10 year, 11.793 kilogram • Drug: MSK, Gel, Topical, Dose: 1 Other per animal, Frequency: 1 per day • Reactions: Deafness, Skin lump • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2016-US-029480
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 10.00 Year
  • Weight: 11.793 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Topical
  • Form: Gel
  • Dose: 1 Other per animal
  • Frequency: 1 per day
Reactions Reported:
Deafness Skin lump
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.